Laboratory features of effects of peloidotherapy and aromatherapy in patients with rheumatoid arthritis

被引:1
|
作者
Pantovic, Snezana M. [1 ]
Roganovic, Milovan B. [2 ]
Slavic, Vjeroslava G. [1 ,3 ]
Zvizdojevic, Jelena M. [4 ]
机构
[1] Univ Montenegro, Fac Med, Krusevac Bb, Podgorica 81000, Montenegro
[2] Clin Ctr Montenegro, Ljubljanska Bb, Podgorica 81000, Montenegro
[3] Rehabil & Rheumatol Dr Simo Milosev, Inst Phys Med, Sava Ilica 5, Herceg Novi 85347, Montenegro
[4] Sci Res Inst Damar, Crnogorskih Serdara Bb, Podgorica 81000, Montenegro
关键词
Peloidotherapy; Aromatherapy; Rheumatoid arthritis; Laboratory results; Effectiveness; PELOID THERAPY; EFFICACY; MANAGEMENT; ELEMENTS; ANXIETY; PAIN;
D O I
10.1007/s00484-024-02630-8
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Peloidotherapy and aromatherapy have been used for years in the treatment of numerous inflammatory conditions, including rheumatoid arthritis (RA). The exact mechanism of their action in RA is unclear. The goal of our research is to determine the effect of peloidotherapy and aromatherapy on inflammation parameters in RA patients. Our study included 20 patients of both sexes, with confirmed diagnosis of RA, older than 18 years. Patients were treated during 28 days with combination of peloidotherapy and aromatherapy. Serum samples for detection of levels of inflammation parameters were taken at two intervals: before the start of therapy and at the end of treatment. The results of our study show that there were no significant changes in the parameters of the complete blood count. Nevertheless, a statistically significant decrease in the serum concentration of two markers of inflammation-interleukin-6 (IL-6) and nitrogen-oxide (NO)-was detected. Correlation analyses results say that there is a synchronized drop in the serum concentrations of CRP and the sedimentation rate, and the serum concentrations of fibrinogen and IL-6 are in the same relationship as well as serum levels of IL-6 and NO. Bearing in mind the importance of IL-6 and NO in the pathogenesis of inflammation in RA, we conclude that the application of our therapeutic protocol can be a significant add-on treatment to classic immunomodulators. Due to the small number of study participants, the lack of a control group, and the short follow-up time of patients, additional research is needed.
引用
收藏
页码:855 / 860
页数:6
相关论文
共 50 条
  • [21] Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis
    Lopez-Pedrera, Chary
    Barbarroja, Nuria
    Patino-Trives, Alejandra M.
    Luque-Tevar, Maria
    Collantes-Estevez, Eduardo
    Escudero-Contreras, Alejandro
    Perez-Sanchez, Carlos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 30
  • [22] Audiological Features in Patients with Rheumatoid Arthritis: A Systematic Review
    Chen, Jiann-Jy
    Hsu, Chih-Wei
    Chen, Yen-Wen
    Chen, Tien-Yu
    Zeng, Bing-Syuan
    Tseng, Ping-Tao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (24)
  • [23] Clinicopathological features of lung cancer in patients with rheumatoid arthritis
    Liu, Xiaoyan
    Xu, Yan
    Zhou, Qing
    Chen, Minjiang
    Liang, Hongge
    Zhao, Jing
    Zhong, Wei
    Wang, Mengzhao
    JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : 3965 - 3972
  • [24] Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports
    Tetsuo Kobayashi
    Satoshi Ito
    Akira Murasawa
    Hajime Ishikawa
    Hiromasa Yoshie
    BMC Rheumatology, 3
  • [25] CLINICAL AND LABORATORY FEATURES OF PATIENTS WITH REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA COMPARED TO PATIENTS WITH SERONEGATIVE RHEUMATOID ARTHRITIS
    Higashida-Konishi, M.
    Izumi, K.
    Hama, S.
    Hayashi, Y.
    Okano, Y.
    Oshima, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 838 - 839
  • [26] Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports
    Kobayashi, Tetsuo
    Ito, Satoshi
    Murasawa, Akira
    Ishikawa, Hajime
    Yoshie, Hiromasa
    BMC RHEUMATOLOGY, 2019, 3 (01)
  • [27] FEATURES OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Lapshina, S.
    Myasoutova, L.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 29 - 29
  • [28] FEATURES OF ANTIPHOSPHOLIPID ANTIBODIES SPECTRUM IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Bashlakova, N.
    Tyabut, T.
    Buglova, A.
    Trushyna, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1339 - 1340
  • [29] EFFECTS OF TERIPARATIDE ON BONE METABOLISM OF PATIENTS WITH RHEUMATOID ARTHRITIS AND NON RHEUMATOID ARTHRITIS
    Kida, D.
    Fujito, T.
    Kanda, H.
    Takahashi, N.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S485 - S486
  • [30] RHEUMATOID ARTHRITIS - LABORATORY PROFILE
    PHILLIPS, DI
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 1974, 73 (05): : 86 - 87